Yokoyama Yasuhiro, Wan Xiaoyun, Takahashi Yuichiro, Shinohara Ariyoshi, Liulin Tang, Tamaya Teruhiko
Department of Obstetrics and Gynecology, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu 500-8705, Japan.
Arch Biochem Biophys. 2002 Sep 1;405(1):32-7. doi: 10.1016/s0003-9861(02)00284-9.
The template region of human telomerase RNA is a crucial area for regulating telomerase activity and would be a good target for ribozymes. In fact, potent telomerase inhibitory activity of the ribozyme targeting the GUC sequence of the 5(') end of this region (36-ribosome) has been well demonstrated. To search for a more potent ribozyme, we designed a divalent ribozyme to cleave both the phosphodiester bonds following the GUC and the 23 nucleotides downstream of GUA. An in vitro cleavage study showed that this divalent ribozyme cleaved telomerase RNA more efficiently than the 36-ribozyme or the 59-ribozyme to target the GUA. When this ribozyme was introduced into the carcinoma cells, its inhibitory effect on telomerase activity was less than that of the 36-ribozyme. The 59-ribozyme showed minimum activity on telomerase. This implies that, although the divalent ribozyme possesses a potent cleavage activity on hTR in vitro, the 36-ribozyme is most potent to suppress telomerase activity.
人端粒酶RNA的模板区域是调节端粒酶活性的关键区域,也是核酶的良好作用靶点。事实上,靶向该区域5(')端GUC序列的核酶(36-核酶)具有很强的端粒酶抑制活性,这一点已得到充分证实。为了寻找更有效的核酶,我们设计了一种二价核酶,用于切割GUC之后的磷酸二酯键以及GUA下游的23个核苷酸。体外切割研究表明,这种二价核酶比36-核酶或靶向GUA的59-核酶更有效地切割端粒酶RNA。当将这种核酶导入癌细胞时,其对端粒酶活性的抑制作用小于36-核酶。59-核酶对端粒酶的活性最低。这意味着,尽管二价核酶在体外对人端粒酶RNA具有很强的切割活性,但36-核酶在抑制端粒酶活性方面最为有效。